Guardian Pharmacy Services

GRDN on NYSE. Guardian Pharmacy Services sells pharmacy services and drugs to care homes and their residents. Market value $412m.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Not a fit for our list right now

See Everyday goods stocks that passed both tests

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
annual report to December 2025
3.3%fair

For every $100 of what the whole company costs, it produced $3.33 of spare cash last year. A savings account pays about $4.

Price to profit
past 12 months to June 2026
29.9×full

You pay 29.9 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
n/a

The filings do not give us enough to work this out.

Quality score: not known. Price score: 32 of 100. Our list needs 70 on quality and 60 on price.

$41.20 a share, 78% above its 1-year low

Over the past year the price has ranged from $23.14 to $48.33.

Pays no dividend

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

0.1
2025
Revenue
$1.4bn
Operating margin
5.0%
Debt to equity
0.03
Shares outstanding
n/a

Health checks

  • Free cash flow positive1 of 1 years
  • Accounting looks honest (Beneish)Not enough data
  • Financial strength (Piotroski)Not enough data
  • Profit backed by cash (accruals)Not enough data
  • Debt0.03× equity
  • Revenue growth, five yearsUnknown

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $352 million last quarter, up 2% on a year ago.
  • Profit: $22 million, up 142% on a year ago.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$314m
March 2025$329m
June 2025$344m
September 2025$377m
December 2025$398m
March 2026$337m
June 2026$352m
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024-$122m
March 2025$9m
June 2025$9m
September 2025$10m
December 2025$21m
March 2026$13m
June 2026$22m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
11 March 2026
Next quarterly (estimated, 10-Q)
5 November 2026

Who owns it

3 long-term investors we follow own it, unchanged from 3 last quarter. 189 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

5 investors own more than 5%.

  • Thomas J. Salentine, Jr.
    Insider or founder
    at least 26.4%+5.1 pts
    (filed with 8 related holders)
    Since 27 September 2026
  • FMR LLC
    Passive investor
    at least 6.5%
    (filed with 1 related holder)
    Since 31 March 2026
  • at least 4.7%
    (filed with 2 related holders)
    Since 31 December 2024
  • at least 3.1%−1.9 pts
    (filed with 2 related holders)
    Since 31 December 2025
  • J. Goldman & Co LP
    Passive investor
    at least 2.9%
    (filed with 2 related holders)
    Since 30 September 2025
  • Woodline Partners LP
    Passive investor
    Sold down below 5%
    Since 31 December 2024
  • Franklin Resources, Inc.
    Passive investor
    Sold down below 5%
    Since 30 June 2025
  • The Vanguard Group
    Passive investor
    Sold down below 5%
    Since 30 June 2025
  • BlackRock, Inc.
    Passive investor
    Sold down below 5%
    Since 31 December 2025
  • TIAA-CREF Investment Management, LLC
    Passive investor
    Sold down below 5%
    Since 30 May 2025
  • Sold down below 5%
    Since 30 June 2025
  • Sold down below 5%
    Since 5 December 2024
  • Nuveen Asset Management, LLC
    Passive investor
    Sold down below 5%
    Since 30 May 2025
  • BROWN INVESTMENT ADVISORY & TRUST CO
    Passive investor
    Sold down below 5%
    Since 31 December 2025
  • Teachers Advisors, LLC
    Passive investor
    Sold down below 5%
    Since 30 May 2025

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 1 insider bought $99,786 of shares on the open market. 6 sold $280m.

  • Morris David K
    See Remarks, Director
    Sold
    Date
    20 March 2026
    Shares
    187,855
    Price
    $29.68
    Value
    $6m
  • Burke Fred
    See Remarks, Director
    Sold
    Date
    20 March 2026
    Shares
    671,432
    Price
    $29.68
    Value
    $20m
  • Salentine Thomas J Jr
    Director
    Sold
    Date
    20 March 2026
    Shares
    3,570,677
    Price
    $29.68
    Value
    $106m
  • Ackerman John
    Director
    Sold
    Date
    20 March 2026
    Shares
    1,103,364
    Price
    $29.68
    Value
    $33m
  • BINDLEY WILLIAM E
    Director
    Sold
    Date
    20 March 2026
    Shares
    3,570,677
    Price
    $29.68
    Value
    $106m
  • Forbes Kendall
    See Remarks
    Sold
    Date
    20 March 2026
    Shares
    346,672
    Price
    $29.68
    Value
    $10m
  • COSLER STEVEN D
    Director
    Bought
    Date
    3 December 2025
    Shares
    3,370
    Price
    $29.61
    Value
    $99,786

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 11 Mar 2026, plus the 10-Q filed 6 Aug 2026 and 7 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

  • It isn't cheap on profits: 29.9× operating profit.

Whether the price already reflects the risks is what the deep dive is for.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from

A big holder just moved. The deep dive shows what the business is worth.

Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.